Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Thoracic 1

Conditions

Lymphoma, Follicular 3Asthma 2Pulmonary Disease, Chronic Obstructive 1Carcinoma, Bronchogenic 1Bronchial Hyperreactivity 1

Interventions

Fluticasone-Salmeterol Drug Combination 3Etanercept 3Fluticasone 2Budesonide 2Beclomethasone 2perflutren 1laninamivir 1fluticasone-formoterol 1Sulfur Hexafluoride 1Prednisolone 1NVP-QAV680 1Lysine Acetyltransferase 5 1Health Information Exchange 1Formoterol Fumarate 1Exercise 1Escitalopram 1CS 8958 1Budesonide, Formoterol Fumarate Drug Combination 1Bronchial Thermoplasty 1Blood Specimen Collection 1Azithromycin 1Amoxicillin-Potassium Clavulanate Combination 1Albuterol 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Asthma × Fluticasone × Clear all
NCT00455923 2018-02-05

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

GlaxoSmithKline

Phase 4 Completed
100 enrolled 8 charts
LymphoidThoracic

Asthma, Lymphoma, Follicular, Bronchial Hyperreactivity

NCT00461500 2017-03-03

SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

GlaxoSmithKline

Phase 4 Completed
81 enrolled 18 charts
Lymphoid

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡